Taiho Oncology, Inc.
Jennifer Hodge has a comprehensive background in clinical operations and research. Jennifer is currently working at Taiho Oncology, Inc. as a Senior Director of Clinical Operations, a role they began in January 2022. Prior to their current position, Jennifer worked at Eli Lilly and Company from 2016 to 2022, where they held various roles including Manager of Clinical Laboratory Sciences, Clinical Program Operations Consultant, and Associate Consultant in Clinical Pharmacology. Before joining Eli Lilly, they served as the Administrator of Protocol Operations at IU Simon Cancer Center from 2015 to 2016. Jennifer also worked as a Team Manager at IUSCC Clinical Research Office from 2012 to 2015, and as a Clinical Research Specialist at IU Simon Cancer Center from 2008 to 2012. Their early experience in the field includes a role as a Clinical Research Coordinator at Mayo Clinic Scottsdale, which they held from 2005 to 2008.
Jennifer Hodge obtained their Bachelor of Science (BS) in Biology/Biological Sciences from Indiana University–Purdue University Indianapolis in the years 1997 to 2002. Jennifer then pursued further education and received a Master of Science (MS) degree in Oncology and Cancer Biology from the same institution between 2002 and 2004. Additionally, Jennifer obtained a certification as a Certified Clinical Research Professional (CCRP) from the Society of Clinical Research in June 2015.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com